Researcher profile

Feiyang Chen

Feiyang Chen contributes to research discovery and scholarly infrastructure.

ResearcherAffiliation not importedOpen to collaborate

Trust snapshot

Quick read

Trust 15 - UnverifiedVerification L1Unclaimed author
3works
0followers
6topics
4close collaborators

Actions

Decide how to stay connected

Follow researcher0

Identity and collaboration

How to connect with this researcher

Claiming links this public author record to a researcher profile and unlocks direct collaboration workflows.

Log in to claim

Direct collaboration

Open a focused conversation when the fit is right

Claim this author entity first to unlock direct invitations.

Research graph

See the researcher in context

Open full explorer

Inspect adjacent work, topics, institutions and collaborators without jumping out to a separate graph page.

Building this graph slice

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

3 published item(s)

preprint2022arXiv

DiffSinger: Singing Voice Synthesis via Shallow Diffusion Mechanism

Singing voice synthesis (SVS) systems are built to synthesize high-quality and expressive singing voice, in which the acoustic model generates the acoustic features (e.g., mel-spectrogram) given a music score. Previous singing acoustic models adopt a simple loss (e.g., L1 and L2) or generative adversarial network (GAN) to reconstruct the acoustic features, while they suffer from over-smoothing and unstable training issues respectively, which hinder the naturalness of synthesized singing. In this work, we propose DiffSinger, an acoustic model for SVS based on the diffusion probabilistic model. DiffSinger is a parameterized Markov chain that iteratively converts the noise into mel-spectrogram conditioned on the music score. By implicitly optimizing variational bound, DiffSinger can be stably trained and generate realistic outputs. To further improve the voice quality and speed up inference, we introduce a shallow diffusion mechanism to make better use of the prior knowledge learned by the simple loss. Specifically, DiffSinger starts generation at a shallow step smaller than the total number of diffusion steps, according to the intersection of the diffusion trajectories of the ground-truth mel-spectrogram and the one predicted by a simple mel-spectrogram decoder. Besides, we propose boundary prediction methods to locate the intersection and determine the shallow step adaptively. The evaluations conducted on a Chinese singing dataset demonstrate that DiffSinger outperforms state-of-the-art SVS work. Extensional experiments also prove the generalization of our methods on text-to-speech task (DiffSpeech). Audio samples: https://diffsinger.github.io. Codes: https://github.com/MoonInTheRiver/DiffSinger. The old title of this work: "Diffsinger: Diffusion acoustic model for singing voice synthesis".

preprint2022arXiv

SingGAN: Generative Adversarial Network For High-Fidelity Singing Voice Generation

Deep generative models have achieved significant progress in speech synthesis to date, while high-fidelity singing voice synthesis is still an open problem for its long continuous pronunciation, rich high-frequency parts, and strong expressiveness. Existing neural vocoders designed for text-to-speech cannot directly be applied to singing voice synthesis because they result in glitches and poor high-frequency reconstruction. In this work, we propose SingGAN, a generative adversarial network designed for high-fidelity singing voice synthesis. Specifically, 1) to alleviate the glitch problem in the generated samples, we propose source excitation with the adaptive feature learning filters to expand the receptive field patterns and stabilize long continuous signal generation; and 2) SingGAN introduces global and local discriminators at different scales to enrich low-frequency details and promote high-frequency reconstruction; and 3) To improve the training efficiency, SingGAN includes auxiliary spectrogram losses and sub-band feature matching penalty loss. To the best of our knowledge, SingGAN is the first work designed toward high-fidelity singing voice vocoding. Our evaluation of SingGAN demonstrates the state-of-the-art results with higher-quality (MOS 4.05) samples. Also, SingGAN enables a sample speed of 50x faster than real-time on a single NVIDIA 2080Ti GPU. We further show that SingGAN generalizes well to the mel-spectrogram inversion of unseen singers, and the end-to-end singing voice synthesis system SingGAN-SVS enjoys a two-stage pipeline to transform the music scores into expressive singing voices. Audio samples are available at \url{https://SingGAN.github.io/}

preprint2021arXiv

BridgeDPI: A Novel Graph Neural Network for Predicting Drug-Protein Interactions

Motivation: Exploring drug-protein interactions (DPIs) work as a pivotal step in drug discovery. The fast expansion of available biological data enables computational methods effectively assist in experimental methods. Among them, deep learning methods extract features only from basic characteristics, such as protein sequences, molecule structures. Others achieve significant improvement by learning from not only sequences/molecules but the protein-protein and drug-drug associations (PPAs and DDAs). The PPAs and DDAs are generally obtained by using computational methods. However, existing computational methods have some limitations, resulting in low-quality PPAs and DDAs that hamper the prediction performance. Therefore, we hope to develop a novel supervised learning method to learn the PPAs and DDAs effectively and thereby improve the prediction performance of the specific task of DPI. Results: In this research, we propose a novel deep learning framework, namely BridgeDPI. BridgeDPI introduces a class of nodes named hyper-nodes, which bridge different proteins/drugs to work as PPAs and DDAs. The hyper-nodes can be supervised learned for the specific task of DPI since the whole process is an end-to-end learning. Consequently, such a model would improve prediction performance of DPI. In three real-world datasets, we further demonstrate that BridgeDPI outperforms state-of-the-art methods. Moreover, ablation studies verify the effectiveness of the hyper-nodes. Last, in an independent verification, BridgeDPI explores the candidate bindings among COVID-19's proteins and various antiviral drugs. And the predictive results accord with the statement of the World Health Organization and Food and Drug Administration, showing the validity and reliability of BridgeDPI.